LONDON--(BUSINESS WIRE)--The RNAi technology market is poised to grow by USD 1.96 billion during 2020-2024, progressing at a CAGR of over 22% during the forecast period.
Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.
Get FREE Sample Report in Minutes!
The report on the RNAi technology market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the adoption of RNAi technology for undruggable targets.
The RNAi technology market analysis includes application segment and geography landscape. This study identifies the recent advances in whole-genome RNAi screening as one of the prime reasons driving the RNAi technology market growth during the next few years.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The RNAi technology market covers the following areas:
RNAi technology Market Sizing
RNAi technology Market Forecast
RNAi technology Market Analysis
Companies Mentioned
- Alnylam Pharmaceuticals Inc.
- Arbutus Biopharma Corp.
- Arrowhead Pharmaceuticals Inc.
- Bio-Rad Laboratories Inc.
- Dicerna Pharmaceuticals Inc.
- F. Hoffmann-La Roche Ltd.
- Horizon Discovery Group Plc
- Merck KGaA
- QIAGEN NV
- Thermo Fisher Scientific Inc.
Related Reports on Health Care Include:
Global Oligonucleotide Therapeutics Market: The oligonucleotide therapeutics market size has the potential to grow by USD 901.18 million during 2020-2024, and the market's growth momentum will accelerate during the forecast period. To get extensive research insights: Click and Get FREE Sample Report in Minutes!
Key Topics Covered:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Value Chain Analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2019
- Market size and forecast 2019-2024
- Market outlook
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY APPLICATION
- Market segmentation by application
- Comparison by application
- Cancer - Market size and forecast 2019-2024
- Infectious diseases - Market size and forecast 2019-2024
- Ophthalmic diseases - Market size and forecast 2019-2024
- Genetic diseases - Market size and forecast 2019-2024
- Other diseases - Market size and forecast 2019-2024
- Market opportunity by application
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
- Growing commercial approvals of RNAi therapy
- Recent advances in whole-genome RNAi screening
- Growing demand for personalized targeted RNAi therapy for cancer
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive scenario
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Alnylam Pharmaceuticals Inc.
- Arbutus Biopharma Corp.
- Arrowhead Pharmaceuticals Inc.
- Bio-Rad Laboratories Inc.
- Dicerna Pharmaceuticals Inc.
- F. Hoffmann-La Roche Ltd.
- Horizon Discovery Group Plc
- Merck KGaA
- QIAGEN NV
- Thermo Fisher Scientific Inc.
PART 14: APPENDIX
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
